These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11412872)

  • 1. Transcriptional activation of the non-muscle, full-length dystrophin isoforms in Duchenne muscular dystrophy skeletal muscle.
    Sironi M; Bardoni A; Felisari G; Cagliani R; Robotti M; Comi GP; Moggio M; Bresolin N
    J Neurol Sci; 2001 May; 186(1-2):51-7. PubMed ID: 11412872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe cardiac involvement with preserved truncated dystrophin expression in Becker muscular dystrophy by +1G>A DMD splice-site mutation: a case report.
    Komaki R; Hashimoto Y; Mori-Yoshimura M; Oya Y; Takizawa H; Minami N; Nishino I; Aoki Y; Takahashi Y
    J Hum Genet; 2020 Oct; 65(10):903-909. PubMed ID: 32504006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
    Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M
    Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional and epigenetic analyses of the DMD locus reveal novel cis‑acting DNA elements that govern muscle dystrophin expression.
    Gherardi S; Bovolenta M; Passarelli C; Falzarano MS; Pigini P; Scotton C; Neri M; Armaroli A; Osman H; Selvatici R; Gualandi F; Recchia A; Mora M; Bernasconi P; Maggi L; Morandi L; Ferlini A; Perini G
    Biochim Biophys Acta Gene Regul Mech; 2017 Nov; 1860(11):1138-1147. PubMed ID: 28867298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of PCR-deletion detection and immunohistochemistry in Brazilian Duchenne and Becker muscular dystrophy patients.
    Werneck LC; Scola RH; Maegawa GH; Werneck MC
    Am J Med Genet; 2001 Oct; 103(2):115-20. PubMed ID: 11568916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategies for Duchenne and Becker dystrophies.
    Voisin V; de la Porte S
    Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism in muscle biopsies of Duchenne and Becker muscular dystrophy patients.
    Anand A; Prabhakar S; Kaul D
    Neurol India; 1999 Sep; 47(3):218-23. PubMed ID: 10514583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy.
    van den Bergen JC; Schade van Westrum SM; Dekker L; van der Kooi AJ; de Visser M; Wokke BH; Straathof CS; Hulsker MA; Aartsma-Rus A; Verschuuren JJ; Ginjaar HB
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):92-8. PubMed ID: 23667215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Central nervous system involvements in Duchenne/Becker muscular dystrophy].
    Kumagai T; Miura K; Ohki T; Matsumoto A; Miyazaki S; Nakamura M; Ochi N; Takahashi O
    No To Hattatsu; 2001 Nov; 33(6):480-6. PubMed ID: 11725514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome expression in the skeletal muscles of patients with muscular dystrophy.
    Kumamoto T; Fujimoto S; Ito T; Horinouchi H; Ueyama H; Tsuda T
    Acta Neuropathol; 2000 Dec; 100(6):595-602. PubMed ID: 11078210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy.
    Al-Jumah M; Majumdar R; Al-Rajeh S; Chaves-Carballo E; Salih MM; Awada A; Al-Shahwan S; Al-Uthaim S
    Saudi Med J; 2002 Dec; 23(12):1478-82. PubMed ID: 12518196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrafamilial phenotypic heterogeneity related to a new DMD splice site variant.
    Coimbra Neto AR; de Carvalho SC; Leoni TB; Iwabe C; Silva TQAC; Coelho-Filho OR; Marques MJ; Nucci A; França MC
    Neuromuscul Disord; 2021 Aug; 31(8):788-797. PubMed ID: 34312044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
    Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
    Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duchenne muscular dystrophy in a female with compound heterozygous contiguous exon deletions.
    Takeshita E; Minami N; Minami K; Suzuki M; Awashima T; Ishiyama A; Komaki H; Nishino I; Sasaki M
    Neuromuscul Disord; 2017 Jun; 27(6):569-573. PubMed ID: 28434908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophinopathies in females.
    Hausmanowa-Petrusewicz I; Fidziańska A; Niebrój-Dobosz I; Dorobek M; Bojakowski J
    Folia Neuropathol; 2000; 38(1):7-12. PubMed ID: 11057028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valley sign in Becker muscular dystrophy and outliers of Duchenne and Becker muscular dystrophy.
    Pradhan S
    Neurol India; 2004 Jun; 52(2):203-5. PubMed ID: 15269471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human.
    Neri M; Torelli S; Brown S; Ugo I; Sabatelli P; Merlini L; Spitali P; Rimessi P; Gualandi F; Sewry C; Ferlini A; Muntoni F
    Neuromuscul Disord; 2007 Dec; 17(11-12):913-8. PubMed ID: 17826093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel deletion at the M and P promoters of the human dystrophin gene associated with a Duchenne muscular dystrophy.
    Frisso G; Sampaolo S; Pastore L; Carlomagno A; Calise RM; Di Iorio G; Salvatore F
    Neuromuscul Disord; 2002 Jun; 12(5):494-7. PubMed ID: 12031623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Transplantation of Bone Marrow-MSCs and Myogenic Stem/Progenitor Cells from Adult Donors Improves Muscle Function of Patients with Duchenne Muscular Dystrophy.
    Klimczak A; Zimna A; Malcher A; Kozlowska U; Futoma K; Czarnota J; Kemnitz P; Bryl A; Kurpisz M
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.